VeriMomdihydroquercetin pentacaprylate hamilelikte güvenli mi?
No harmonised CLP reproductive classification or SCCS/CIR safety assessment was found for dihydroquercetin pentacaprylate. Peer‑reviewed animal and in vitro studies on the parent compound (taxifolin/dihydroquercetin) report no evidence of intrinsic reproductive/teratogenic hazard and in some cases show protective effects against chemical‑induced reproductive damage, so there is no credible evidence to up‑rank hazard. (See CosIng listing for the INCI and PubMed studies on taxifolin.) Sources: EU Official Journal (Cosmetic ingredient listing), PubMed studies on taxifolin reproductive effects.
Related ingredients
Frequently asked questions
- dihydroquercetin pentacaprylate hamilelikte güvenli mi?
- No harmonised CLP reproductive classification or SCCS/CIR safety assessment was found for dihydroquercetin pentacaprylate. Peer‑reviewed animal and in vitro studies on the parent compound (taxifolin/dihydroquercetin) report no evidence of intrinsic reproductive/teratogenic hazard and in some cases show protective effects against chemical‑induced reproductive damage, so there is no credible evidence to up‑rank hazard. (See CosIng listing for the INCI and PubMed studies on taxifolin.) Sources: EU Official Journal (Cosmetic ingredient listing), PubMed studies on taxifolin reproductive effects.
- dihydroquercetin pentacaprylate emzirirken güvenli mi?
- No data specific to lactation or breastmilk transfer for the pentacaprylate or parent dihydroquercetin were located. Because there is no evidence of reproductive toxicity or endocrine disruption for the parent and no harmonised flags, hazard and mechanism remain 0. Exposure from topical cosmetic use was not shown to be high. No SCCS/CIR contraindication found.
- dihydroquercetin pentacaprylate bebek cildi için güvenli mi?
- Hazard/mechanism: no infant‑specific reproductive or developmental hazard data were found for this derivative or for taxifolin; peer‑reviewed work shows taxifolin is not a reproductive teratogen and can be protective in rodent models, so h/m remain 0. Exposure: no dermal absorption data for the pentacaprylate were located. Per instructions, when adult topical absorption evidence is lacking but the ingredient is not absolutely non‑absorbable, increase baby exposure by +1 due to higher baby surface‑area:body‑weight and immature barrier.
- VeriMom dihydroquercetin pentacaprylate nasıl puanlıyor?
- VeriMom dihydroquercetin pentacaprylate'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte dihydroquercetin pentacaprylate yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.